Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Alleanza Holdings, 16% Increase in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
3546 Alleanza Holdings Co., Ltd. 【J-GAAP】
Earnings ReportAlleanza Holdings Co., Ltd. <3546> [TSE Prime] announced its financial results after the market closed on April 10th (15:30). The consolidated ordinary profit for the fiscal year ended February 2026 increased by 15.7% from the previous period to 4.57 billion yen, exceeding the previous forecast of 4.25 billion yen. Furthermore, the company did not disclose the performance outlook for the fiscal year ending February 2027.
At the same time, the company has left the annual dividend for the current term undetermined.
In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit decreased to 0.94 billion yen, a 16.6% decrease compared to the same period last year. The operating profit margin worsened from 2.7% in the same period last year to 2.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb, 2024 | 149,715 | 4,106 | 4,614 | 2,372 | 78.7 | 38 | Apr 10, 2024 | J-GAAP |
| Feb, 2025 | 153,345 | 3,509 | 3,953 | 2,088 | 69.4 | 38 | Apr 10, 2025 | J-GAAP |
| Feb, 2026 | 150,601 | 4,098 | 4,574 | 2,544 | 84.8 | 19 | Apr 10, 2026 | J-GAAP |
| YoY | -1.8% | +16.8% | +15.7% | +21.8% | +22.2% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb, 2026 Guidance | 155,000 | 3,750 | 4,250 | 2,200 | 73.3 | 19 | Feb 13, 2026 | J-GAAP |
| Feb, 2026 Results | 150,601 | 4,098 | 4,574 | 2,544 | 84.8 | 19 | Apr 10, 2026 | J-GAAP |
| Revision Rate | -2.8% | +9.3% | +7.6% | +15.6% | +15.7% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar - Aug, 2025 | 78,126 | 3,039 | 3,297 | 2,023 | 67.4 | 19 | Oct 10, 2025 | J-GAAP |
| Mar - Aug, 2026 Guidance | ー | ー | ー | ー | - | - | Apr 10, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb, 2025 | 153,345 | 3,509 | 3,953 | 2,088 | 69.4 | 38 | Apr 10, 2025 | J-GAAP |
| Feb, 2026 | 150,601 | 4,098 | 4,574 | 2,544 | 84.8 | 19 | Apr 10, 2026 | J-GAAP |
| Feb, 2027 Guidance | ー | ー | ー | ー | - | - | Apr 10, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec - Feb, 2024 | 37,787 | 1,013 | 1,134 | 251 | 8.3 | 2.7 | Apr 10, 2025 | J-GAAP |
| Mar - May, 2025 | 39,283 | 1,500 | 1,645 | 990 | 33.0 | 3.8 | Jul 10, 2025 | J-GAAP |
| Jun - Aug, 2025 | 38,843 | 1,539 | 1,652 | 1,033 | 34.4 | 4.0 | Oct 10, 2025 | J-GAAP |
| Sep - Nov, 2025 | 36,173 | 239 | 331 | 237 | 7.9 | 0.7 | Jan 13, 2026 | J-GAAP |
| Dec - Feb, 2025 | 36,302 | 820 | 946 | 284 | 9.5 | 2.3 | Apr 10, 2026 | J-GAAP |
| YoY | -3.9% | -19.1% | -16.6% | +13.1% | +13.4% |
Related Articles
Hobonichi, First Half Ordinary Profit Increases by 65%, Exceeds Full-Year Plan
RINGER HUT, 28% Increase in Ordinary Profit for The Current Fiscal Year
HIMARAYA, First Half Ordinary Profit Revised Downward to a Loss
Daito Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 17%
Bewith Inc, Dec-Feb (3Q) Ordinary Profit Increases by 2.0 times
Mobilus, First Half Ordinary Profit Turns to Loss, Dec-Feb Ordinary Profit Decreases by 69%
WATTS, First Half Ordinary Profit Unexpectedly Revised Upward by 3%
CNS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 9%, Exceeded Record Profit Forecast, Dividend Revised Upward by 5 Yen
DAIKOKUTENBUSSAN, Jun-Feb (Cumulative 3Q) Ordinary Profit Decreases by 42%, Dec-Feb Ordinary Profit Decreases by 52%
HOKKO CHEMICAL, Dec-Feb (1Q) Ordinary Profit Increases by 20%